Market Place
Sourcing Support
Bristol Myers Squibb Showcases Camzyos Real-World Results at ESC
29 Aug 2025 //
PHARMAWEB
Bristol Myers Squibb to Unveil Clinical Data at ESC Congress 2025
25 Aug 2025 //
PHARMAWEB
FDA Approves Agilent MMR IHC Panel for Colorectal Cancer
20 Aug 2025 //
BUSINESSWIRE
BMS’ Breyanzi Accepted for Review in Marginal Zone Lymphoma
04 Aug 2025 //
BUSINESSWIRE
Bristol Myers Squibb`s Q2 2025 Financial Results Released
31 Jul 2025 //
BUSINESSWIRE
BMS Highlights Commercial Success Amid Clinical Setbacks
31 Jul 2025 //
FIERCE BIOTECH
BMS` Cobenfy Future Uncertain After Phase III Failure
31 Jul 2025 //
BIOSPACE
Bristol Myers, Bain form New Company to Develop Immunology Drug
29 Jul 2025 //
REUTERS
Bristol Myers Squibb Appoints New Evp, Chief Medical Officer
25 Jul 2025 //
CONTRACTPHARMA
BMS`s sNDA for Sotyktu in Psoriatic Arthritis Under Review
21 Jul 2025 //
BUSINESSWIRE
BMS` Anemia Drug Reblozyl Flunks Phase III Myelofibrosis Trial
19 Jul 2025 //
BIOSPACE
BMS, Pfizer offer Eliquis to patients at 40% below list price
18 Jul 2025 //
FIERCE PHARMA
BioNTech`s Chief Strategy Officer Heads for The Exit
17 Jul 2025 //
FIERCE BIOTECH
BMS Opens RayzeBio Radiopharma Production Site in Indianapolis
15 Jul 2025 //
FIERCE PHARMA
Onco360 named national specialty pharmacy for Augtyro
07 Jul 2025 //
GLOBENEWSWIRE
Biokin, having landed BMS deal, posts ph. 3 Bispecific ADC win
03 Jul 2025 //
FIERCE BIOTECH
BMS`s Biologics Opdivo Receive Suppl Approval in US
01 Jul 2025 //
FDA
FDA Eliminates Risk Evaluation, Mitigation for Car-T Therapies
28 Jun 2025 //
REUTERS
FDA Updates Bristol Myers Squibb Cell Therapy Label, Removes REMS
26 Jun 2025 //
BUSINESSWIRE
Cigna Files Anti-Competition Lawsuit Against BMS Over Pomalyst
25 Jun 2025 //
FIERCE PHARMA
Bristol Myers Squibb Announces Dividend
17 Jun 2025 //
BUSINESSWIRE
Biogen, BMS and Novartis bag spots on Cannes Lions shortlists
16 Jun 2025 //
FIERCE PHARMA
BMS Taps Biotech Analyst to Lead Long-Term Strategy
13 Jun 2025 //
FIERCE BIOTECH
Bristol Myers Squibb to Report Q2 2025 Results on July 31, 2025
12 Jun 2025 //
BUSINESSWIRE
BMS Shows CELMoD BCL6 Degrader Data at EHA 2025
12 Jun 2025 //
BUSINESSWIRE
Bristol Myers CEO Stays Bullish on Cobenfy despite trial flop
12 Jun 2025 //
FIERCE PHARMA
BMS`s Deucravacitinib Shows Superiority in Psoriatic Arthritis
12 Jun 2025 //
BUSINESSWIRE
RayzeBio bags Philochem’s Cancer Radiotracer in $1.35B deal
11 Jun 2025 //
GLOBENEWSWIRE
FDA limits Merck`s Keytruda, BMS` Opdivo in Stomach Cancer
10 Jun 2025 //
FIERCE PHARMA
Markey Researchers Get $6.8M For Lung Cancer Screening Model
06 Jun 2025 //
ACCESSWIRE
ASCO: Bristol CMO brushes off LAG-3 concern after melanoma flop
03 Jun 2025 //
FIERCE PHARMA
Bristol Myers Squibb gets EU approval for Opdivo Subcutaneous
28 May 2025 //
BUSINESSWIRE
BMS to Join Goldman Sachs Global Healthcare Conference
28 May 2025 //
BUSINESSWIRE
BMS`s Biologics Yervoy Receives Suppl Approval in US
23 May 2025 //
FDA
BMS`s Biologics Opdivo Receives Suppl Approval in US
23 May 2025 //
FDA
BMS`s Biologics Opdivo Qvantig Receives Suppl Approval in US
23 May 2025 //
FDA
Bristol Myers Squibb to Present Data at ASCO® 2025
22 May 2025 //
BUSINESSWIRE
Bristol Myers Squibb at Bernstein 41st Annual Strategic Decisions
21 May 2025 //
BUSINESSWIRE
Tubulis Hits Milestone in BMS License as Tubutecan ADC
20 May 2025 //
GLOBENEWSWIRE
Breakthroughs in KRAS Inhibitor Scaffolds
16 May 2025 //
PRESS RELEASE
Bristol Myers gets EU approval for Opdivo regimen in lung Cancer
16 May 2025 //
BUSINESSWIRE
Hawaii settles for $700 million with Bristol-Myers, Sanofi
12 May 2025 //
REUTERS
BMS’ Augtyro (Repotrectinib) Approved in Canada
07 May 2025 //
HEALTH CANADA
BMS`s Augtyro Receives Approval in Canada
07 May 2025 //
HEALTH CANADA
Strengthening Local Health System Capacity for Better Care
07 May 2025 //
ACCESSWIRE
2seventy bio Reports Q1 Results, Update on BMS Acquisition
07 May 2025 //
BUSINESSWIRE
Bristol Myers Squibb Names Cari Gallman EVP, General Counsel & CPO
06 May 2025 //
BUSINESSWIRE
BMS prunes NJ workforce again, this time to tune of 500+ jobs
06 May 2025 //
FIERCE PHARM
Bristol Myers to invest $40 billion in the US over 5 years
06 May 2025 //
REUTERS
BMS to Close Libertyville Viral Vector Production Facility
02 May 2025 //
CONTRACTPHARMA
BMS Reports Mixed Earnings as Portfolio due to Generic Pressure
26 Apr 2025 //
BIOSPACE
Bristol Myers Squibb`s Q1 2025 Financial Results Reported
24 Apr 2025 //
BUSINESSWIRE
BMS Cobenfy fails in key study as add-on treatment for schizophrenia
23 Apr 2025 //
PRESS RELASE
FDA Updates Camzyos Label to Reduce Monitoring Requirements
17 Apr 2025 //
BUSINESSWIRE
OpenFold AI Research Consortium Welcomes New Members
15 Apr 2025 //
BUSINESSWIRE
BMS` heart disease drug fails to meet main goals in study
15 Apr 2025 //
PRESS RELEASE
BMS`s Biologic Yervoy Receives Suppl Approval in US
11 Apr 2025 //
FDA
BMS`s Biologic Opdivo Receives Suppl Approval in US
11 Apr 2025 //
FDA
FDA approves Opdivo and Yervoy for Hepatocellular Carcinoma
11 Apr 2025 //
BUSINESSWIRE
Bristol Myers wins dismissal of lawsuit alleging Pomalyst monopoly
09 Apr 2025 //
REUTER
